Warburg Pincus-Led Investor Group Agrees to Acquire Controlling Interest in PANTHERx® Rare
Investment will support continued innovation in rare disease care and help PANTHERx serve more patients while preserving its independent, patient-first model NEW YORK and PITTSBURGH, July 13, 2026 /PRNewswire/ -- Warburg Pincus, the pioneer of global growth investing, today announced that...
Investment will support continued innovation in rare disease care and help PANTHERx serve more patients while preserving its independent, patient-first model NEW YORK and PITTSBURGH, July 13, 2026 /PRNewswire/ -- Warburg Pincus, the pioneer of global growth investing, today announced that...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.